ACU Form 4: Paul J. Conway Exercises Options for 2,500 ACU Shares

Rhea-AI Filing Summary

Paul J. Conway, a director of Acme United Corp (ACU), reported a securities transaction on Form 4. The filing shows an employee stock option exercise on 08/12/2025 that acquired 2,500 shares of Common Stock at a conversion/exercise price of $43.4 per share. Following the reported transaction, Mr. Conway beneficially owns 7,500 shares. The Form 4 is signed and dated 08/14/2025 and lists Mr. Conway's address in Shelton, CT. No additional derivatives, dispositions, or indirect ownership details are included in the filing.

Positive

• Director reported an increase in direct ownership to 7,500 shares following the transaction
• Transparent Section 16 disclosure filed and manually signed, dated 08/14/2025
• Transaction is clearly documented with date (08/12/2025), quantity (2,500 shares) and price ($43.4)

Negative

• None.

Insights

Securities Analyst

TL;DR: Director exercised options for 2,500 shares at $43.40, increasing direct beneficial ownership to 7,500 shares.

The Form 4 documents a routine insider option exercise by Paul J. Conway on 08/12/2025. The exercise price is shown as $43.4 and the transaction increased his direct common stock holdings to 7,500 shares. This disclosure is a standard Section 16 filing that notifies the market of a change in beneficial ownership and provides transparency on insider holdings. No sales, pledges, or indirect holdings are reported, and there are no other derivative positions disclosed in this filing.

Corporate Governance Expert

TL;DR: Filing is a routine, compliant disclosure of an option exercise by a company director.

The Form 4 is properly executed and identifies Paul J. Conway as a director. It reports the acquisition of 2,500 shares via exercise of an employee stock option on 08/12/2025 with an exercise/conversion price of $43.4 and shows 7,500 shares beneficially owned post-transaction. From a governance and disclosure perspective, the document supplies the key elements required under Section 16 for insider transaction transparency. No amendments or additional complexities are indicated.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Conway Paul J

(Last) (First) (Middle)

1 WATERVIEW DRIVE

(Street)

SHELTON CT 06484

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
ACME UNITED CORP [ ACU ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
08/12/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option	$43.4	08/12/2025	08/12/2025	A		2,500		08/13/2025	08/12/2035	Common Stock	2,500	$43.4	7,500	D

Explanation of Responses:

	/s/ Paul J. Conway	08/14/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transaction did Paul J. Conway report on Form 4 for ACU?

The filing reports an employee stock option exercise on 08/12/2025 that acquired 2,500 shares of ACU common stock.

How many ACU shares does Paul J. Conway beneficially own after the reported transaction?

Following the reported transaction, Paul J. Conway beneficially owns 7,500 shares of ACU common stock.

What was the exercise or conversion price per share reported on the Form 4?

The Form 4 shows a conversion/exercise price of $43.4 per share.

What is Paul J. Conway’s relationship to Acme United Corp (ACU)?

The filing identifies Paul J. Conway as a Director of Acme United Corp.

When was the Form 4 signed and filed?

The Form 4 is signed by Paul J. Conway and dated 08/14/2025.